top of page
MarkVCID Project
MarkVCID is a consortium of US academic medical centers whose mission is to identify and validate biomarkers for the small vessel diseases of the brain that produce vascular contributions to cognitive impairment and dementia (VCID). The overall goal of the consortium is to deliver high-quality biomarkers ready for use in clinical trials aimed at generating scientific breakthroughs in our understanding and treatment of VCID.
Anchor 1
Our Role in MarkVCID Study
​
BrainSigns is the fluid-based biomarker site representative of this project at Johns Hopkins University. We process and measure biomarkers in the fluid samples sent to us in this project.
bottom of page